These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33664981)

  • 1. Venous thromboembolism in pregnancy-diagnosis, management, and treatment.
    Kearsley R; Stocks G
    BJA Educ; 2021 Mar; 21(3):117-123. PubMed ID: 33664981
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of thromboembolic disease associated with pregnancy.
    Evans W; Laifer SA; McNanley TJ; Ruzycky A
    J Matern Fetal Med; 1997; 6(1):21-7. PubMed ID: 9029380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboembolism in pregnancy: challenges and controversies in the prevention of pregnancy-associated venous thromboembolism and management of anticoagulation in women with mechanical prosthetic heart valves.
    McLintock C
    Best Pract Res Clin Obstet Gynaecol; 2014 May; 28(4):519-36. PubMed ID: 24814194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of venous thromboembolism secondary to ovarian hyperstimulation syndrome: A case report documenting the first use of a superior vena caval filter for upper limb venous thromboembolism in pregnancy, and the difficulties and complications relating to anticoagulation in antenatal and peri-partum periods.
    Mitchell-Jones N; McEwan M; Johnson M
    Obstet Med; 2016 Jun; 9(2):93-5. PubMed ID: 27512501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Trends in the Duration of Anticoagulant Therapy for Venous Thromboembolism: A Systematic Review.
    Alexander P; Visagan S; Issa R; Gorantla VR; Thomas SE
    Cureus; 2021 Oct; 13(10):e18992. PubMed ID: 34853735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of venous thromboembolism: a systematic review for a practice guideline.
    Segal JB; Streiff MB; Hofmann LV; Thornton K; Bass EB
    Ann Intern Med; 2007 Feb; 146(3):211-22. PubMed ID: 17261856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.
    Price DT; Ridker PM
    Ann Intern Med; 1997 Nov; 127(10):895-903. PubMed ID: 9382368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cumulative incidence of venous thromboembolism during pregnancy and puerperium: a hospital-based study.
    Soomro RM; Bucur IJ; Noorani S
    Angiology; 2002; 53(4):429-34. PubMed ID: 12143948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decision-Making in the Management of Venous Thromboembolism.
    Ellis MH; Avnery O
    Am J Med; 2021 Mar; 134(3):317-325. PubMed ID: 33289662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation period in idiopathic venous thromboembolism. How long is enough?
    Farraj RS
    Saudi Med J; 2004 Jul; 25(7):848-51. PubMed ID: 15235686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and treatment of deep-vein thrombosis and approach to venous thromboembolism in obstetrics and gynecology.
    Burgazlı KM; Bilgin M; Kavukçu E; Altay MM; Ozkan HT; Coşkun U; Akdere H; Ertan AK
    J Turk Ger Gynecol Assoc; 2011; 12(3):168-75. PubMed ID: 24591986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation duration in heterozygous factor V Leiden: a decision analysis.
    Donovan AK; Smith KJ; Ragni MV
    Thromb Res; 2013; 132(6):724-8. PubMed ID: 24112753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of venous thromboembolism risk and prophylaxis among hospitalized patients in Brazzaville].
    Ikama SM; Nkoua MF; Gombet TR; Makani J; Mongo-Ngamami S; Ondze-Kafata LI; Ellenga-Mbolla BF; Kimbally-Kaky G
    J Mal Vasc; 2016 May; 41(3):182-7. PubMed ID: 26970811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Prolonged Anticoagulation with Rivaroxaban on Provoked Venous Thromboembolism Recurrence: IMPROVE-VTE.
    Coleman CI; Turpie AGG; Bunz TJ; Beyer-Westendorf J; Baker WL
    Am J Med; 2019 Apr; 132(4):498-504. PubMed ID: 30582894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of patients with venous thromboembolism and malignant disease: should vena cava filter placement be routine?
    Ihnat DM; Mills JL; Hughes JD; Gentile AT; Berman SS; Westerband A
    J Vasc Surg; 1998 Nov; 28(5):800-7. PubMed ID: 9808846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulation in patients with isolated distal deep vein thrombosis: a meta-analysis.
    Franco L; Giustozzi M; Agnelli G; Becattini C
    J Thromb Haemost; 2017 Jun; 15(6):1142-1154. PubMed ID: 28316124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Venous Thromboembolism in Pregnancy.
    Fogerty AE
    Curr Treat Options Cardiovasc Med; 2018 Jul; 20(8):69. PubMed ID: 30039233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis and treatment of venous thromboembolism in patients with cancer: the Saudi clinical practice guideline.
    Al-Hameed F; Al-Dorzi HM; AlMomen A; Algahtani F; AlZahrani H; AlSaleh K; AlSheef M; Owaidah T; Alhazzani W; Neumann I; Wiercioch W; Brozek J; Schünemann H; Akl EA
    Ann Saudi Med; 2015; 35(2):95-106. PubMed ID: 26336014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anticoagulation in Venous Thromboembolism: How Long and Which Dose?].
    Machado M; Ruosch-Girsberger S; Hegglin A; Wuillemin WA
    Praxis (Bern 1994); 2020; 109(4):270-276. PubMed ID: 32183654
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.